EBOS Group Limited ( (AU:EBO) ) just unveiled an announcement.
EBOS Group Limited has announced a change in the director’s interest, with Stuart McLauchlan acquiring 39 additional ordinary shares through a dividend reinvestment plan, bringing his total to 2,535 shares. This change reflects the company’s ongoing commitment to aligning director interests with shareholder value, potentially strengthening stakeholder confidence in the company’s governance practices.
More about EBOS Group Limited
EBOS Group Limited operates in the healthcare and animal care sectors, providing a range of products and services including pharmaceutical distribution, medical equipment, and animal health products. The company focuses on serving the Australasian market, leveraging its extensive distribution network to meet the needs of healthcare and animal care professionals.
YTD Price Performance: 1.46%
Average Trading Volume: 43,681
Technical Sentiment Signal: Sell
Current Market Cap: A$6.64B
For detailed information about EBO stock, go to TipRanks’ Stock Analysis page.